litlas
Log inCreate account

Ying E. Zhang

Active 1995–2024

58
Papers
19,359
Citations
48
h-index
57
i10-index

Citations

Citations per year for Ying E. Zhang1995: 2 citations1996: 14 citations1997: 109 citations1998: 172 citations1999: 237 citations2000: 276 citations2001: 247 citations2002: 147 citations2003: 227 citations2004: 209 citations2005: 230 citations2006: 195 citations2007: 189 citations2008: 155 citations2009: 229 citations2010: 213 citations2011: 232 citations2012: 274 citations2013: 197 citations2014: 230 citations2015: 191 citations2016: 205 citations2017: 221 citations2018: 185 citations2019: 638 citations2020: 635 citations2021: 617 citations2022: 469 citations2023: 313 citations2024: 552 citations2025: 189 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,607 citing papers, 30.3% of this breakdownChina: 1,571 citing papers, 18.3% of this breakdownJapan: 438 citing papers, 5.1% of this breakdownGermany: 369 citing papers, 4.3% of this breakdownUnited Kingdom: 365 citing papers, 4.2% of this breakdownCanada: 283 citing papers, 3.3% of this breakdownFrance: 247 citing papers, 2.9% of this breakdownSouth Korea: 205 citing papers, 2.4% of this breakdownNetherlands: 202 citing papers, 2.4% of this breakdownItaly: 190 citing papers, 2.2% of this breakdownAustralia: 183 citing papers, 2.1% of this breakdownSweden: 163 citing papers, 1.9% of this breakdown
0%30.3%Other 20.6%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology55.4%
  • Medicine36.2%
  • Immunology and Microbiology4.4%
  • Neuroscience1.7%
  • Engineering0.6%
  • Agricultural and Biological Sciences0.5%
  • Other1.2%

Topics

  • TGF-β signaling in diseases11.1%
  • Bone Metabolism and Diseases2.2%
  • Cancer Cells and Metastasis2.1%
  • Cancer-related gene regulation2.1%
  • Pancreatic and Hepatic Oncology Research2.1%
  • MicroRNA in disease regulation2%
  • Other78.4%

Coauthors

All papers

Open in search
  1. Smad-dependent and Smad-independent pathways in TGF-β family signalling

    Authors: Rik Derynck, Ying E. Zhang - Nature 2003 cited by 5,375

  2. Non-Smad pathways in TGF-β signaling

    Authors: Ying E. Zhang - Cell Research 2008 cited by 1,707

  3. Non-Smad Signaling Pathways of the TGF-β Family

    Authors: Ying E. Zhang - Cold Spring Harbor Perspectives in Biology 2016 cited by 690

  4. Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway

    Authors: Liu-Ya Tang, Mary Heller, Zhaojing Meng, Li‐Rong Yu, Yi Tang, Ming Zhou, Ying E. Zhang - Journal of Biological Chemistry 2017 cited by 271

  5. TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β

    Authors: Motozo Yamashita, Károly Fátyol, Chaoyang Jin, Xiangchun Wang, Zheng-gang Liu, Ying E. Zhang - Molecular Cell 2008 cited by 551

  6. Transcriptional Activators of TGF-β Responses: Smads

    Authors: Rik Derynck, Ying E. Zhang, Xin‐Hua Feng - Cell 1998 cited by 1,036

  7. Image-based genome-wide siRNA screen identifies selective autophagy factors

    Authors: Anthony Orvedahl, Rhea Sumpter, Guanghua Xiao, Aylwin Ng, Zhongju Zou, Yi Tang, Masahiro Narimatsu, Christopher J. Gilpin, Qihua Sun, Michael G. Roth, Christian V. Forst, Jeffrey L. Wrana, Ying E. Zhang, Katherine Luby‐Phelps, Ramnik J. Xavier, Yang Xie, Beth Levine - Nature 2011 cited by 480

  8. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription

    Authors: Ying E. Zhang, Xin‐Hua Feng, Rik Derynck - Nature 1998 cited by 809

  9. TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses

    Authors: Li‐Rong Yu, Mindy C. Hébert, Ying E. Zhang - The EMBO Journal 2002 cited by 727

  10. Alternative splicing in EMT and TGF-β signaling during cancer progression

    Authors: Ying E. Zhang, Christina H. Stuelten - Seminars in Cancer Biology 2024 cited by 63

  11. Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β

    Authors: Veenu Tripathi, Katherine M. Sixt, Shaojian Gao, Xuan Xu, Jing Huang, Roberto Weigert, Ming Zhou, Ying E. Zhang - Molecular Cell 2016 cited by 104

  12. Role of miR-143 targeting KRAS in colorectal tumorigenesis

    Authors: Xiaoli Chen, Xu Guo, Hao Zhang, Yang Xiang, J. Chen, Y Yin, Xianwei Cai, Kang Wang, Gaohong Wang, Yi Ba, Lin Zhu, Jie Wang, Rong Yang, Ying E. Zhang, Z. Ren, K Zen, J. Zhang, C-Y Zhang - Oncogene 2009 cited by 550

  13. T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation

    Authors: Eric Tu, Cheryl Chia, Weiwei Chen, Dunfang Zhang, Sang A Park, Wenwen Jin, Dandan Wang, Maria‐Luisa Alegre, Ying E. Zhang, Lingyun Sun, Wanjun Chen - Immunity 2018 cited by 94

  14. Ubiquitin Ligase Smurf1 Controls Osteoblast Activity and Bone Homeostasis by Targeting MEKK2 for Degradation

    Authors: Motozo Yamashita, Saixia Ying, Gen‐Mu Zhang, Cuiling Li, Steven Y. Cheng, Chu‐Xia Deng, Ying E. Zhang - Cell 2005 cited by 358

  15. Tumor Necrosis Factor Promotes Runx2 Degradation through Up-regulation of Smurf1 and Smurf2 in Osteoblasts

    Authors: Hiroyuki Kaneki, Ruolin Guo, Di Chen, Zhenqiang Yao, Edward M. Schwarz, Ying E. Zhang, Brendan F. Boyce, Lianping Xing - Journal of Biological Chemistry 2005 cited by 305

  16. Receptor-associated Mad homologues synergize as effectors of the TGF-β response

    Authors: Ying E. Zhang, Xin‐Hua Feng, Rui-Yun Wu, Rik Derynck - Nature 1996 cited by 878

  17. TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance

    Authors: Veenu Tripathi, Jee‐Hye Shin, Christina H. Stuelten, Ying E. Zhang - Oncogene 2019 cited by 97

  18. Mechanistic insight into contextual TGF-β signaling

    Authors: Ying E. Zhang - Current Opinion in Cell Biology 2017 cited by 96

  19. Opposing functions of circadian protein DBP and atypical E2F family E2F8 in anti-tumor Th9 cell differentiation

    Authors: Sang-a Park, Yun-Ji Lim, Wai Lim Ku, Dunfang Zhang, Kairong Cui, Liu-Ya Tang, Cheryl Chia, Peter Zanvit, Zuojia Chen, Wenwen Jin, Dandan Wang, Junji Xu, Ousheng Liu, Fu Wang, Alexander Cain, Nancy Lan Guo, Hiroko Nakatsukasa, Chuan Wu, Ying E. Zhang, Keji Zhao, WanJun Chen - Nature Communications 2022 cited by 21

  20. Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment

    Authors: Christina H. Stuelten, Ying E. Zhang - Frontiers in Cell and Developmental Biology 2021 cited by 59

  21. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase

    Authors: Ying E. Zhang, Chenbei Chang, Daniel J. Gehling, Ali Hemmati‐Brivanlou, Rik Derynck - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 520

  22. Ablation of Smurf2 reveals an inhibition in TGF‐β signalling through multiple mono‐ubiquitination of Smad3

    Authors: Liu-Ya Tang, Motozo Yamashita, Nathan P. Coussens, Yi Tang, Xiangchun Wang, Cuiling Li, Chu‐Xia Deng, Steven Y. Cheng, Ying E. Zhang - The EMBO Journal 2011 cited by 133

  23. FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration

    Authors: Yuanjie Liu, Jie-pin Li, Ying E. Zhang, Mengjun Nie, Yonghua Zhang, Shen-Lin Liu, Xi Zou - OncoTargets and Therapy 2021 cited by 41

  24. The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for Smad3 in TGF-β-induced transcriptional activation

    Authors: Xin‐Hua Feng, Ying E. Zhang, Rui-Yun Wu, Rik Derynck - Genes & Development 1998 cited by 531